Allena Pharmaceuticals Receives $15,000,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3613c363-bf7a-4dac-9cca-d6e1829f7a4e&Preview=1 -
Date
11/17/2011 -
Company Name
Allena Pharmaceuticals -
Mailing Address
One Newton Executive Park Newton, MA 02462 -
Company Description
Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions. -
Website
http://www.allenapharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$15,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds from the financing will be used to accelerate the development of Allena’s non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions. -
M&A Terms
-
Venture Investor
Bessemer Venture Partners -
Venture Investor
Frazier Healthcare Ventures -
Venture Investor
Third Rock Ventures -
Venture Investor
Undisclosed
